Using antibodies to treat disease has been one of the great success stories of early 21st-century medicine. Already five of the ten top-selling pharmaceuticals in the United States are antibody products. But antibodies are ...
Mar 2, 2017
1
337
With much of society now effectively in lockdown, how will we know when it's safe to resume something like normality?
Mar 31, 2020
0
10
Scientists at The University of Manchester and Central Manchester University Hospitals NHS Foundation Trust have made a significant breakthrough in the fight against Membranous Nephropathy (MN) – a rare kidney disease which ...
May 19, 2015
0
1219
Last year, pathologist Jeffrey SoRelle, M.D., and colleagues developed CoVarScan, a rapid COVID-19 test that detects the signatures of eight hotspots on the SARS-CoV-2 virus. Now, after testing CoVarScan on more than 4,000 ...
Jul 3, 2022
0
175
Researchers have found a new mechanism in which an antibody can prevent allergic reactions in a broad range of patients. Their discovery could pave the way for a far more effective allergy medicine. The team of researchers ...
Jan 26, 2018
0
75
A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, ...
Aug 17, 2011
0
1
Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).
Dec 16, 2016
0
58
If one is good, two can sometimes be better. Researchers at the California Institute of Technology (Caltech) have certainly found this to be the case when it comes to a small HIV-fighting protein.
Jul 29, 2011
0
0
Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of ...
Nov 1, 2012
1
0
Sophie Lucas (University of Louvain de Duve Institute) and her team have succeeded in neutralizing a molecule that blocks the immune system against cancer. The UCLouvain scientists discovered that this new immunotherapy increases ...
Sep 11, 2020
0
27
